Evidence supporting the use of: Hawthorn
For the health condition: Arteriosclerosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Hawthorn (Crataegus spp.) has a long history of traditional use in Europe for cardiovascular conditions, particularly heart failure and circulatory disorders. In recent decades, scientific research has begun to investigate its potential benefits for conditions like arteriosclerosis (the thickening and hardening of artery walls), though the evidence is moderate and not definitive.

Hawthorn contains various bioactive compounds, including flavonoids and oligomeric proanthocyanidins, which are believed to contribute to its cardiovascular effects. These compounds exhibit antioxidant, anti-inflammatory, and vasodilatory properties. Several animal and in vitro studies suggest that hawthorn extracts can reduce oxidative stress and inhibit processes that contribute to the development of arteriosclerosis, such as endothelial dysfunction and lipid peroxidation.

Clinical evidence, while promising, is limited. Some small-scale human trials and meta-analyses have shown that hawthorn extract may improve parameters related to cardiovascular health, such as blood pressure, endothelial function, and blood lipid profiles. However, most of these studies have focused on heart failure rather than arteriosclerosis specifically, and few are of sufficient size or quality to make definitive claims.

Overall, there is moderate scientific support for hawthorn’s use in promoting cardiovascular health, which indirectly supports its use in arteriosclerosis. However, more rigorous clinical trials are needed to establish efficacy and safety specifically for this condition. Hawthorn is generally considered safe when used as directed, but it may interact with certain cardiovascular medications.

More about hawthorn
More about Arteriosclerosis